Therefore, we suggest that myo-inositol is a candidate in vivo marker to study the impact of APOE ε4 on the interplay between astrocytes and the pathophysiology of Alzheimer’s disease. Here, APOE is linked to early-onset autosomal dominant Alzheimer disease.